Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT
Bone Marrow Transplantation, Published online: 08 August 2023; doi:10.1038/s41409-023-02075-4Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT
Source: Bone Marrow Transplantation - Category: Hematology Authors: Jaime Sanz Myriam Labopin Thomas Pabst Jurjen Versluis Gwendolyn Van Gorkom Ellen Meijer Tobias Gedde-Dahl Juan Montoro William Arcese Jose Antonio P érez-Simón Nicolaas Schaap Johan Maertens Radovan Vrhovac Francesco Lanza Norbert Claude Gorin Mohamad Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Bone Marrow Transplant | Hematology | Leukemia | Stem Cell Therapy | Stem Cells | Study | Transplants